Total Issue Amount : USD 1,000,000 Subscription Agreement Execution Date: [5/16], 2023 Payment Date and Issue Date: [5/16], 2023Convertible Bond Subscription Agreement • May 16th, 2024 • Exicure, Inc. • Pharmaceutical preparations
This Convertible Bond Subscription Agreement (the “Agreement”) is made and entered into by and among the following parties as of [5/16], 2023.
Separation and Release AgreementSeparation and Release Agreement • May 16th, 2024 • Exicure, Inc. • Pharmaceutical preparations • Illinois
This Separation and Release Agreement (the “Agreement”) by and between Exicure, Inc. (the “Company”) and Elias Papadimas (“You” or “Your”) (the Company and You collectively referred to as the “Parties”), is entered into and effective as of April 26, 2023 (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 16th, 2024 • Exicure, Inc. • Pharmaceutical preparations • Illinois
This EMPLOYMENT AGREEMENT (the “Agreement”), by and among Exicure, Inc. (the “Company”) and Jung S. Kim (“You” or “Your”) (the Company and You each a “Party”, and collectively the “Parties”), is entered into and effective as of April 27, 2023 (the “Effective Date”).1
Separation and Release AgreementSeparation and Release Agreement • May 16th, 2024 • Exicure, Inc. • Pharmaceutical preparations • Illinois
This Separation and Release Agreement (the “Agreement”) by and between Exicure, Inc. (the “Company”) and Matthias Schroff (“You” or “Your”) (the Company and You collectively referred to as the “Parties”), is entered into and effective as of April 26, 2023 (the “Effective Date”).
Amended and Restated Employment AgreementEmployment Agreement • May 16th, 2024 • Exicure, Inc. • Pharmaceutical preparations • Illinois
This Employment Agreement (the “Agreement”) between Exicure, Inc., a Delaware corporation (the “Company”), and Joshua Miller (“Executive”) (each of Executive and the Company, a “Party,” and collectively, the “Parties”), is entered into as of May 9, 2023.
May 5, 2023 Joshua Miller Re: Retention Agreement Dear Josh:Retention Agreement • May 16th, 2024 • Exicure, Inc. • Pharmaceutical preparations
Thank you for all of your contributions to Exicure, Inc. (the “Company”). Your role is key to our success and we are excited to offer you the retention award described below pursuant to the terms and conditions set forth in this agreement (this “Retention Agreement”). This Retention Agreement will be effective as of May 5, 2023, provided that you have executed and returned it to the Company on or before such date.
FIRST AMENDMENT TO THE SEPARATION & RELEASE AGREEMENT OF MATTHIAS SCHROFFSeparation & Release Agreement • May 16th, 2024 • Exicure, Inc. • Pharmaceutical preparations
This First Amendment To The Separation & Release Agreement Of Matthias Schroff (the “Amendment”) is effective as of the 12th day of June, 2023 (the “Effective Date”), by and between Matthias Schroff (the former “Executive”) and EXICURE, INC. (the “Company”) (each of the former Executive and the Company, a “Party,” and collectively, the “Parties”).
Separation and Release AgreementSeparation Agreement • May 16th, 2024 • Exicure, Inc. • Pharmaceutical preparations • Illinois
This Separation and Release Agreement (the “Agreement”) by and between Exicure, Inc. (the “Company”) and Sarah Longoria (“You” or “Your”) (the Company and You collectively referred to as the “Parties”), is entered into and effective as of May 26, 2023 (the “Effective Date”).
